Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark J. Meltzer sold 6,000 shares of Intuitive Surgical stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $419.98, for a total value of $2,519,880.00. Following the completion of the sale, the senior vice president now directly owns 11,552 shares of the company’s stock, valued at approximately $4,851,608.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Intuitive Surgical, Inc. (NASDAQ ISRG) opened at $427.51 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $242.26 and a fifty-two week high of $452.00. The firm has a market capitalization of $48,890.00, a price-to-earnings ratio of 50.18, a P/E/G ratio of 4.96 and a beta of 0.50.
Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, January 25th. The medical equipment provider reported $2.54 EPS for the quarter, topping the Zacks’ consensus estimate of $2.27 by $0.27. The company had revenue of $892.40 million for the quarter, compared to analysts’ expectations of $866.54 million. Intuitive Surgical had a return on equity of 19.93% and a net margin of 21.09%. The firm’s quarterly revenue was up 17.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.03 earnings per share. research analysts expect that Intuitive Surgical, Inc. will post 7.85 earnings per share for the current fiscal year.
A number of equities research analysts have recently commented on the company. BidaskClub raised Intuitive Surgical from a “buy” rating to a “strong-buy” rating in a research report on Thursday, January 11th. Barclays reaffirmed an “overweight” rating and issued a $465.00 price objective on shares of Intuitive Surgical in a research report on Thursday, January 11th. Citigroup lowered their price objective on Intuitive Surgical to $507.00 and set a “buy” rating for the company in a research report on Tuesday, February 6th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $490.00 price objective on shares of Intuitive Surgical in a research report on Friday, January 26th. Finally, Vetr raised Intuitive Surgical from a “buy” rating to a “strong-buy” rating and set a $443.17 price objective for the company in a research report on Thursday, February 8th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company. The stock has an average rating of “Buy” and an average target price of $408.48.
Institutional investors and hedge funds have recently modified their holdings of the business. First Trust Advisors LP lifted its stake in shares of Intuitive Surgical by 61.4% during the third quarter. First Trust Advisors LP now owns 51,130 shares of the medical equipment provider’s stock worth $53,476,000 after purchasing an additional 19,458 shares in the last quarter. Davis R M Inc. acquired a new position in shares of Intuitive Surgical during the third quarter worth about $219,000. Point72 Asset Management L.P. acquired a new position in shares of Intuitive Surgical during the third quarter worth about $24,264,000. Chevy Chase Trust Holdings Inc. lifted its stake in shares of Intuitive Surgical by 206.2% during the fourth quarter. Chevy Chase Trust Holdings Inc. now owns 179,792 shares of the medical equipment provider’s stock worth $65,613,000 after purchasing an additional 121,082 shares in the last quarter. Finally, Atria Investments LLC lifted its stake in shares of Intuitive Surgical by 189.4% during the fourth quarter. Atria Investments LLC now owns 1,777 shares of the medical equipment provider’s stock worth $648,000 after purchasing an additional 1,163 shares in the last quarter. Institutional investors own 61.59% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This news story was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this news story on another domain, it was stolen and reposted in violation of United States & international trademark and copyright law. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2018/02/24/intuitive-surgical-inc-isrg-svp-mark-j-meltzer-sells-6000-shares.html.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.